Forte Biosciences, Inc.FBRXNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, modest growth trend.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-36.60M
↓ 40% below average
Average (9y)
$-26.09M
Historical baseline
Range
High:$-4.06M
Low:$-45.85M
CAGR
+5.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-36.60M | -12.7% |
| 2023 | $-32.49M | -133.8% |
| 2022 | $-13.90M | +35.3% |
| 2021 | $-21.49M | -51.0% |
| 2020 | $-14.22M | -250.0% |
| 2019 | $-4.06M | +91.1% |
| 2018 | $-45.85M | -21.9% |
| 2017 | $-37.63M | -18.7% |
| 2016 | $-31.69M | -38.1% |
| 2015 | $-22.95M | - |